myNEO Therapeutics
PrivateLast Round
Accelerator
Jul 1, 2020
Total Funding Raised
$2.35M
Company Overview
myNEO Therapeutics is a biotechnology company that develops therapeutic cancer vaccines by applying artificial intelligence to identify novel cancer targets from the 'dark genome'.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Precision Medicine, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share, Data as a Service
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
myNEO Therapeutics Comparables
Compare myNEO Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Cartography Biosciences | 79% | |
| Evaxion A/S | 79% | |
| Geneos Therapeutics | 77% |
myNEO Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Jul 1, 2020 | ||||
| Grant | Mar 2, 2020 | ||||
| Seed | Dec 27, 2018 | ||||
| Seed | Dec 27, 2018 |
myNEO Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Start it @KBC | Accelerator |
| VLAIO | Grant |
| Novalis Biotech | Seed |
| Endless Frontier Labs | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 7, 2026
Monthly visitors grew 2331% MoM, reaching 5.3K.
- Mar 1, 2026
Monthly visitors increased 60% MoM, from 136 to 218.
myNEO Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about myNEO Therapeutics's valuation, stock price, and market status.
Is myNEO Therapeutics a public or private company?
myNEO Therapeutics is a private company.
What is the current stock price of myNEO Therapeutics?
myNEO Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is myNEO Therapeutics worth (valuation)?
Valuation information for myNEO Therapeutics is not publicly available.
Can I buy myNEO Therapeutics stock?
myNEO Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was myNEO Therapeutics's last funding round?
myNEO Therapeutics's most recent funding round was Accelerator on July 1, 2020.
Who are the main investors in myNEO Therapeutics?
Key investors in myNEO Therapeutics include Novalis Biotech.
Will myNEO Therapeutics IPO soon?
No public IPO plans have been announced for myNEO Therapeutics.
How can I track myNEO Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor myNEO Therapeutics's secondary market activity and sign up for updates.